David Pearson1, Maxime Garnier1, Alexandre Luneau2
1a Pharmacokinetic Sciences , Novartis Institutes for BioMedical Research , Novartis Pharma AG , Basel , Switzerland.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Leniolisib, a PI3K delta inhibitor, is primarily eliminated via metabolism, with drug-related material excreted in urine and feces. This study demonstrates effective mass balance determination without radiolabeling.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: